CAS: 16751-01-2

Neryl monophosphate lithium salt is a chinese patent that has been shown to be effective in treating polycystic ovary syndrome. It is an ancillary drug which may be used to treat other conditions such as tissue cultures, and can be used as a diagnostic tool for insulin resistance. This drug is also a modifier of nature and can be used in pharmaceutical formulations. Neryl monophosphate lithium salt has been shown to have metabolic disorders such as the synthesis of reaction products that are involved in the metabolism of carbohydrates, lipids, and proteins.